Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05572073 · ClinicalTrials.gov registry record
Otoferlin Gene-mediated Hearing Loss Natural History Study
A clinical trial of Sensorineural Hearing Loss, Bilateral, sponsored by Akouos.
- Recruiting
- Registry status
- 150
- Enrollment target
- 10
- Study locations
NCT05572073: Recruiting study of Sensorineural Hearing Loss, Bilateral, sponsored by Akouos.
NCT05572073 is a study of Sensorineural Hearing Loss, Bilateral that is actively recruiting participants, run by Akouos. The registered enrollment target is 150 participants, above the 70-participant average among 4 other Sensorineural Hearing Loss, Bilateral trials with a reported enrollment target (114% higher). The trial reports 10 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05572073, a study of Sensorineural Hearing Loss, Bilateral, is actively recruiting participants, sponsored by Akouos.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.
Primary Outcome
Auditory Brainstem Response
Conditions Studied
Interventions
- OTHER Natural History Study
Study Locations (10)
Other
- University Hospital in Tübingen - Tübingen
- National Taiwan University Hospital - Taipei
Iowa
- University of Iowa - Iowa City
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Tennessee
- Vanderbilt University Medical Center - Nashville
Victoria
- Murdoch Children's Research Institute - Parkville
Barcelona
- Sant Joan de Déu Barcelona Hospital - Esplugues de Llobregat
Turkey
- Ankara University - Ankara
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-07-14 |
| Est. Completion | 2029-02 |
What NCT05572073 shows while recruiting
NCT05572073 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 70-participant average among 4 other Sensorineural Hearing Loss, Bilateral trials with a reported enrollment target (114% higher).
The record links to 1 condition, with Sensorineural Hearing Loss, Bilateral appearing as the primary indexed condition, and to 1 intervention - of which Natural History Study is the first listed.
NCT05572073 lists 10 locations in 9 states (Other, Iowa, Ohio).
Frequently Asked Questions
What is clinical trial NCT05572073 about?
NCT05572073 is a clinical study titled "Otoferlin Gene-mediated Hearing Loss Natural History Study". This is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.
What is the current status of trial NCT05572073?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2022-07-14. Estimated completion is 2029-02.
What conditions does trial NCT05572073 study?
This clinical trial studies the following conditions: Sensorineural Hearing Loss, Bilateral.
What interventions are being tested in trial NCT05572073?
The interventions under investigation include: Natural History Study (OTHER).
Who is sponsoring clinical trial NCT05572073?
This trial is sponsored by Akouos, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05572073 being conducted?
This trial has 10 study locations across Iowa, Ohio, Pennsylvania, Tennessee, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensorineural Hearing Loss, Bilateral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
RECRUITING · Phase 1
-
Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis
RECRUITING
-
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
ACTIVE NOT RECRUITING · NA
-
Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI